Radiation Keratosis

Clinical and Pathological Features

Causes and How Radiation Damages the Skin

• Sources of Chronic Ionizing Radiation Exposure:
  • Previous radiation therapy for cancer: The most common cause. Lesions appear 10–20 years later within the treatment field for breast cancer, head and neck cancer, lymphoma or sarcoma.
  • Occupational and historical medical exposure: Radiologists and interventional cardiologists with long-term, inadequately shielded X-ray exposure; nuclear reactor operators; and workers who inspect welds with gamma rays (industrial radiography).
• Cell Damage and Epidermal Dysplasia (Radiation Carcinogenesis):
  • Direct double-strand DNA breaks and reactive oxygen species: Ionizing radiation directly breaks the phosphodiester bonds of DNA and splits water molecules, releasing a wave of hydroxyl radicals (•OH) that cause double-strand breaks (DSBs).
  • Mutations in the tumor suppressor gene TP53: When DNA repair fails, permanent mutations build up in TP53, and keratinocytes lose control of their cell cycle.
  • Obliterative endarteritis and chronic ischemia: Radiation destroys small dermal vessels, scarring and blocking them. Chronic low oxygen (hypoxia) triggers abnormal VEGF release, which encourages malignant change and impairs the tissue's ability to repair itself.
  • Connective tissue changes (radiation fibrosis): Atypical "radiation fibroblasts" multiply and dermal collagen becomes fibrotic, creating a microenvironment that makes it easier for tumor cells to invade.

Clinical Features

The lesions always arise on skin with chronic radiodermatitis, which has a mottled, thinned, poikiloderma-like appearance:

• Background of Chronic Radiodermatitis:
  • Thin, inelastic skin that looks shiny and creased or feels hard like a scar.
  • Prominent, net-like dilated small vessels (telangiectasia).
  • Complete loss of hair follicles, sebaceous glands and sweat glands within the radiation field.
  • Patches of dark brown hyperpigmentation mixed with pale white hypopigmentation.
• What Radiation Keratoses Look Like:
  • Keratotic papules or plaques 3–10 mm across, gray-yellow, light brown or skin-colored.
  • A rough, sandpaper-like surface with scale that sticks firmly to the skin beneath.
  • Often multifocal, scattered across the whole of the old radiation field.
• Signs of Malignant Transformation:
  • A keratosis that thickens quickly, a persistent sore that bleeds easily, or a firm, infiltrated nodule at the base suggests progression to invasive cSCC or BCC.
  • Oncology note: Cancers arising on irradiated skin have a 3–5 times higher risk of spreading to lymph nodes than ordinary sun-related skin cancers.

Histopathology

• Epidermal Dysplasia:
  • Hyperkeratosis with parakeratosis.
  • Basal and spinous keratinocytes lose their polarity and have enlarged, dark, irregular nuclei, with abnormal mitoses high in the epidermis.
• Characteristic Radiation-Induced Dermal Changes:
  • Radiation fibroblasts: Very large fibroblasts with bizarre, giant nuclei and abundant amorphous cytoplasm but no mitotic figures.
  • Collagen homogenization: Dermal collagen bundles become denatured, stiff and fused into uniform pink masses.
  • Obliterative endarteritis: The walls of small dermal vessels are markedly thickened, with narrowed or completely blocked lumens.

Differential Diagnosis and Immunohistochemistry (IHC)

Our Approach to Radiation Keratosis

Because radiation-damaged skin heals very poorly, Haute-Derma manages radiation keratosis with particular care:

• Avoiding Overly Deep Procedures That Leave Non-Healing Ulcers: Irradiated skin is chronically short of blood. Aggressive procedures can lead to skin necrosis and chronic ulcers that are hard to heal.
• Regular Dermoscopic Screening of the Radiation Field: The entire old treatment field is examined carefully every 3–6 months to catch dysplasia at the earliest microscopic stage.
• Preferring Tissue-Sparing Treatment and Margin-Controlled Excision (Mohs Surgery): When surgery is needed, a micrographic technique is used to preserve as much healthy tissue as possible.

Diagnosing Radiation Keratosis at Haute-Derma

• Detailed Radiation History: We record the radiation dose (Gy), treatment field, when radiotherapy ended (usually more than 10 years earlier) or any occupational X-ray exposure.
• High-Resolution Dermoscopy:
  • Background skin: branching or net-like dilated vessels on an ivory-white, fibrotic structureless background.
  • Radiation keratosis: gray-white scale, irregular dotted vessels and complete loss of follicular openings.
• Skin Biopsy (Punch / Incisional): Taken carefully from raised, cracked or suspicious lesions. Special closure techniques are used to reduce the risk of necrosis at the biopsy edges.
• Immunohistochemistry (p53, Ki-67, p63): Grades the degree of dysplasia and stratifies the risk of progression to invasive squamous cell carcinoma.

Specialized Treatments at Haute-Derma

• Fractional UltraPulse CO2 Laser: Our preferred option. Rather than stripping a large area and risking ulcers and scars, the fractional CO2 laser creates tiny columns of thermal injury that vaporize the dysplastic keratin while leaving bridges of healthy tissue in between, so the skin can regenerate quickly even on a chronically ischemic base.
• Field Therapy:
  • Imiquimod 3.75% / 5% cream: Applied on an intermittent schedule, it activates the local immune system to recognize and destroy keratinocytes carrying radiation-induced mutations.
  • 5-fluorouracil cream (5-FU 0.5%–5%): Used at lower strengths together with barrier-repairing moisturizers to avoid excessive skin erosion.
• Modified Photodynamic Therapy (PDT): The photosensitizer MAL or 5-ALA is applied with a shorter incubation time, and the red light (630 nm) dose is adjusted for irradiated skin, selectively destroying dysplastic keratinocytes without further damage to the dermal collagen network.
• Mohs Micrographic Surgery: Required once radiation keratosis has progressed to cSCC or BCC. Mohs surgery examines the complete surgical margin under the microscope, so cancer cells can be cleared while preserving as much of the remaining healthy tissue as possible.
• Oral Retinoid (Acitretin): Low doses (10–25 mg/day) for widespread, multifocal radiation keratoses to normalize epidermal differentiation and help prevent new cancers.